Anti-cancer Activity, and Molecular Docking of Novel Hybrid Heterocyclic Steroids Revealed Promising Anti-hepatocellular Carcinoma Agent: Implication of Cyclin Dependent kinase-2 Pathway.

Tantawy MA, Shalby AB, El-Bernawy I, Kattan SW, Abd-Rabou AA, Elmegeed GA. Anti-cancer Activity, and Molecular Docking of Novel Hybrid Heterocyclic Steroids Revealed Promising Anti-hepatocellular Carcinoma Agent: Implication of Cyclin Dependent kinase-2 Pathway. Steroids. 2023:109187.